Clinical Trial Update: A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating camoteskimab in adults with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Camoteskimab (camoteskimab)

Snippet

Sponsor: Apollo Therapeutics Ltd | Conditions: Atopic Dermatitis, Atopic | Phase 2 | Status: COMPLETED